EFTA Document EFTA01462405

Deutsche Bank Markets Research Rating Buy North America United States Health Care Biotechnology Company Gilead Sciences Alert Reuters GILD.OQ Bloomberg GILD US Exchange NMS Ticker GILD Atripla recall is NOT an issue - DB thoughts post mgmt convo We have gotten many questions around Gilead's Atripla and the voluntary recall that posted to the FDA site. We spoke to mgmt and here is their take MGMT COLOR: On a typical quality check Gilead found small particles and proactivel